Caplacizumab in children: confirm diagnosis, tailor dose
Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100232
DOI: 10.1016/j.bvth.2026.100232 ↗Kurz gefasst
Leserbrief in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Tang-Her Jaing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Zitieren
APA
Jaing, T. H., & Wang, Y. L. (2026). Caplacizumab in children: confirm diagnosis, tailor dose. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100232. https://doi.org/10.1016/j.bvth.2026.100232
Vancouver
Jaing TH, Wang YL. Caplacizumab in children: confirm diagnosis, tailor dose. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100232. doi:10.1016/j.bvth.2026.100232
BibTeX
@article{Jaing2026,
author = {Jaing, Tang-Her and Wang, Yi-Lun},
title = {Caplacizumab in children: confirm diagnosis, tailor dose},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2026},
volume = {3},
number = {4},
pages = {100232},
doi = {10.1016/j.bvth.2026.100232}
}
EUVIMED